Navigation Links
Vascular Health Sciences Introduces Executive and Advisory Team
Date:12/23/2012

Salt Lake City, UT (PRWEB) December 23, 2012

Vascular Health Sciences, in an effort to help its customers and stakeholders get to know the company’s executive team, has published a “Meet the Team” page on VascularHealthSciences.com with biographical and historical background information.

The page introduces Co-Founder and Chief Executive Officer Bob Long; Co-Founder and Chief Operating Officer David Daniels; Co-Founder and Senior Vice President of Product Development Bruce Bouche, DC; Chief Science Officer Nathalie Chevreau, PhD, RD; and the advisory team, which includes Medical Advisor Derrick DeSilva Jr., MD; and Science Advisor Hans Vink, Ph.D.

About Vascular Health Sciences
Founded in 2010, Vascular Health Sciences explores technologies, develops products and disseminates information to increase awareness and promote the proper care of the endothelial glycocalyx. Vascular Health Sciences is committed to increasing awareness of the glycocalyx and its role in vascular health, and to providing products supporting the care of this essential system. For more information, visit VascularHealthSciences.com.

Read the full story at http://www.prweb.com/releases/2012/12/prweb10257189.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related medicine news :

1. Study shows heart calcium scan predictive of diabetes-related death from cardiovascular disease
2. High hormone levels put young black males at risk for cardiovascular disease
3. Pure Cocoa Powder, the Key Ingredient in Dark Chocolate and Found in Diabetes Support Supplements has been Clinically Proven to Reduce Cardiovascular Risk
4. Frequency of alcohol consumption and cardiovascular risk factors
5. Protein tug of war points toward better therapies for cardiovascular disease
6. Timing of first menstrual cycle may be predictor of cardiovascular disease risk in women
7. Controlling vascular disease may be key to reducing prevalence of Alzheimers disease
8. US Hispanics at high risk for cardiovascular disease
9. $1.8 million grant supports investigation of psoriasis link to cardiovascular disease
10. Cardiovascular disease community calls for tougher targets to curb global risk
11. OSA increases cardiovascular mortality in the elderly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
Breaking Medicine Technology: